Literature DB >> 15662808

Volume reduction in meningiomas after gamma knife surgery.

Guenther C Feigl1, Otto Bundschuh, Alireza Gharabaghi, Madjid Samii, Gerhard A Horstmann.   

Abstract

OBJECT: The purpose of this study was to evaluate the volume-reducing effects of gamma knife surgery (GKS) of meningiomas with and without previous surgical treatment.
METHODS: A group of 127 patients with a mean age of 57.1 years (range 9-81 years) with 142 meningiomas (128 World Health Organization Grade I and 14 Grade II) were included in this study. The management strategy reduces tumor volume with surgery when necessary (81 patients). Stereotactic GKS with a Gamma Knife model C was performed in all tumors of suitable size. Magnetic resonance imaging follow-up examinations with volumetric tumor analysis was performed 6 months after treatment and annually thereafter. The mean tumor volume was 5.9 cm3 (range < 5 to > 40 cm3). The mean follow-up time after GKS was 29.3 months (range 11-61 months). The mean prescription dose was 13.8 Gy (range 10-18 Gy). A reduction in volume occurred in 117 (82.4%) of all tumors, and in 20 tumors (14.1%) growth ceased. The overall tumor control rate of 96.4%. The mean volume reduction achieved with GKS was more than 46.1%. Only five tumors (3.5%) stowed a volume increase.
CONCLUSIONS: Gamma knife surgery was effective in reducing meningioma volume at short-term follow up. Further studies are needed to examine the development of these findings over a longer period.

Entities:  

Mesh:

Year:  2005        PMID: 15662808     DOI: 10.3171/jns.2005.102.s_supplement.0189

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  2 in total

1.  Multisession stereotactic radiosurgery for large benign brain tumors of >3cm- early clinical outcomes.

Authors:  Azhar Rashid; Muhammad Ali Memon; Usman Ahmed; Muhammad Abid Saleem; Amer Iqtidar Bhatti; Naveed Ahmed; Abdul Sattar M Hashim
Journal:  J Radiosurg SBRT       Date:  2012

2.  Expression of merlin, NDRG2, ERBB2, and c-MYC in meningiomas: relationship with tumor grade and recurrence.

Authors:  B R Ongaratti; C B O Silva; G Trott; T Haag; C G S Leães; N P Ferreira; M C Oliveira; J F S Pereira-Lima
Journal:  Braz J Med Biol Res       Date:  2016-03-18       Impact factor: 2.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.